Drug:
Reaction: HYPERSENSITIVITY
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26915457 |
CA |
36 | |
Lupus-like syndrome, Arthritis, Nasal congestion, Epistaxis, Infection, Hypersensitivity, Pain, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 202 | 26915468 |
US |
2 | |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 203 | 26915496 |
CA |
44 | 2 |
Rheumatic fever, Duodenal ulcer perforation, Rheumatoid arthritis, Joint range of motion decreased, Inflammation, Rash, Mobility decreased, Pruritus, Sinusitis, Hypoaesthesia, Weight increased, Infusion related reaction, Joint swelling, Dry mouth, Swelling, Glossodynia, Rheumatoid factor positive, Hand deformity, General physical health deterioration, Liver disorder, Wound, Sciatica, Hypertension, Insomnia, Helicobacter infection, Synovitis, Lip dry, Hypersensitivity, Sleep disorder due to general medical condition, insomnia type, Pyrexia, Road traffic accident, Vomiting, Off label use, Wheezing, Fatigue, Sleep disorder, Hepatic enzyme increased, Psoriatic arthropathy, Folliculitis, Drug intolerance, Fibromyalgia, Urticaria, Facet joint syndrome, Ill-defined disorder, Infection, Swollen joint count increased, C-reactive protein abnormal, Stomatitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Irritable bowel syndrome, Impaired healing, Product use in unapproved indication, Medication error, Therapy non-responder, Drug ineffective, Treatment failure, Injury, Malaise, Therapeutic product effect decreased, |
||||
DICLOFENAC SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, NEOMYCIN OINTMENT, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOCILIZUMAB, TOCILIZUMAB, SECUKINUMAB, SECUKINUMAB, GOLIMUMAB, GOLIMUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, TRAMADOL HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VITAMIN C, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREGABALIN, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, VITAMIN C, VITAMIN C, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREMILAST, APREMILAST, APREMILAST, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CELECOXIB, CELECOXIB, CELECOXIB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CELECOXIB, CELECOXIB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, APREPITANT, DOXYCYCLINE, DOXYCYCLINE HYCLATE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRAMADOL HYDROCHLORIDE, |
||||
| 204 | 26915596 |
US |
33 | 2 |
Hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 205 | 26915719 |
BR |
2 | |
Vulvovaginal injury, Spinal fracture, Vein rupture, Metastases to bone, Metastases to spine, Metastases to liver, Metastasis, Haemorrhage, Hydronephrosis, Urinary retention, Seizure, Breast cancer, Malignant neoplasm progression, Nail cuticle fissure, Epistaxis, Dry skin, Dry mouth, Constipation, Vulvovaginal dryness, Drug ineffective, Petechiae, Skin tightness, Visual impairment, Skin fissures, Skin atrophy, Dry throat, Nasal mucosal disorder, Rhinalgia, Secretion discharge, Insomnia, Throat irritation, Hair texture abnormal, Skin exfoliation, Breast disorder, Tumour marker increased, Calcification metastatic, Weight increased, Flatulence, Reflux gastritis, Hiatus hernia, Gastritis, Muscle spasms, Vitamin B12 deficiency, Feeding disorder, Balance disorder, Head injury, Fall, Dermal absorption impaired, Thermal burn, Nasal congestion, Eye swelling, Phlebitis, Rhinitis allergic, Allergic sinusitis, Decreased immune responsiveness, Gastric polyps, Skeletal injury, Pelvic bone injury, Epistaxis, Oropharyngeal discomfort, Hypersensitivity, Discomfort, Quality of life decreased, Rectocele, Bone lesion, Product distribution issue, Thinking abnormal, Feeling abnormal, Carbohydrate antigen 15-3 increased, PIK3CA-activated mutation, Quality of life decreased, Feeding disorder, Sensory disturbance, Skin discolouration, COVID-19, Bone pain, Condition aggravated, Anosmia, Malaise, Gene mutation, Urinary tract infection, Oral pain, Muscle injury, Hepatic mass, Dysbiosis, Oral disorder, Speech disorder, Chills, Lip swelling, Gait disturbance, Gastrointestinal disorder, Pain, Depressed mood, Myalgia, Atrophic vulvovaginitis, Nasal disorder, Head injury, Malaise, Tumour marker abnormal, Central nervous system lesion, Hepatic lesion, Cervix disorder, Uterine leiomyoma, Bacteriuria, Swelling face, Pruritus, Erythema, White blood cell count decreased, Nausea, Peripheral swelling, Vomiting, Diarrhoea, Nasopharyngitis, Dizziness, Abdominal pain upper, Cough, Retching, Fatigue, Sinusitis, Infection, Rhinitis, Abdominal pain, Dyspnoea, Abdominal discomfort, Drug resistance, Pain, Pain in extremity, Head discomfort, Decreased appetite, Vision blurred, Illness, Weight decreased, Arthralgia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PANTOPRAZOLE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALPELISIB, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, EXEMESTANE, CLONAZEPAM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ERGOCALCIFEROL, |
||||
| 206 | 26915895 |
US |
||
Swelling, Lip blister, Hypersensitivity, |
||||
AMLODIPINE BESYLATE, |
||||
| 207 | 26915922 |
US |
68 | 2 |
Headache, Head discomfort, Vision blurred, Balance disorder, Tremor, Drug ineffective, Dizziness, Palpitations, Hypersensitivity, Product substitution issue, Therapeutic response changed, |
||||
AMLODIPINE BESYLATE, PANTOPRAZOLE SODIUM, CLOPIDOGREL, SIMVASTATIN, |
||||
| 208 | 26916080 |
US |
23 | 2 |
Hypersensitivity, Urticaria, Pruritus, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 209 | 26916190 |
GB |
81 | 1 |
Urosepsis, Fungal infection, Hypersensitivity, |
||||
DAPAGLIFLOZIN, IRON, LANSOPRAZOLE, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 210 | 26916310 |
US |
2 | |
Chest pain, Hypersensitivity, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 211 | 26916590 |
US |
25 | 2 |
Choking, Oesophagitis, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 212 | 26916605 |
US |
1 | |
Hypersensitivity, |
||||
DUPILUMAB, ALFUZOSIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OLMESARTAN MEDOXOMIL, EZETIMIBE, FINASTERIDE, HYDROCHLOROTHIAZIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, PREGABALIN, ESOMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, |
||||
| 213 | 26916705 |
US |
2 | |
Hypersensitivity, Cellulitis, Off label use, |
||||
POLIDOCANOL, |
||||
| 214 | 26916835 |
44 | 2 | |
Asthenia, Bursitis, Confusional state, Deep vein thrombosis, Dizziness, General physical health deterioration, Hypersensitivity, Insomnia, Lip dry, Pain in extremity, Rheumatoid arthritis, Swelling, Synovitis, Systemic lupus erythematosus, Tachycardia, Treatment failure, Upper respiratory tract infection, Visual impairment, Walking aid user, Weight decreased, Weight fluctuation, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, Medication error, Off label use, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, |
||||
| 215 | 26916941 |
US |
9 | 1 |
Hypersensitivity, Off label use, |
||||
RITUXIMAB, FERROUS SULFATE, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, WARFARIN, |
||||
| 216 | 26917378 |
US |
57 | 1 |
Hypersensitivity, Chest pain, |
||||
TRASTUZUMAB-QYYP, IVERMECTIN, MEBENDAZOLE, TESTOSTERONE CYPIONATE, ANASTROZOLE, ANASTROZOLE TABLETS, PEMBROLIZUMAB, TRAMADOL HYDROCHLORIDE, |
||||
| 217 | 26917445 |
US |
||
Hypersensitivity, Rash, Urticaria, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 218 | 26917783 |
US |
2 | |
Hypersensitivity, |
||||
ILOPERIDONE, |
||||
| 219 | 26917787 |
EU |
49 | 2 |
Hypersensitivity, Occupational exposure to product, |
||||
NITRIC OXIDE, |
||||
| 220 | 26917796 |
US |
2 | |
Post-traumatic stress disorder, Hypersensitivity, Nasal congestion, Urinary incontinence, Major depression, Off label use, |
||||
ILOPERIDONE, ILOPERIDONE, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 221 | 26917802 |
US |
27 | 2 |
Hypersensitivity, Urticaria, |
||||
ILOPERIDONE, OXCARBAZEPINE, SERTRALINE, |
||||
| 222 | 26917804 |
US |
2 | |
Face oedema, Eye oedema, Swelling face, Eye swelling, Hypersensitivity, |
||||
ILOPERIDONE, |
||||
| 223 | 26917821 |
US |
||
Hypersensitivity, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 224 | 26917910 |
US |
||
Hypersensitivity, |
||||
ANIFROLUMAB-FNIA, ANIFROLUMAB-FNIA, |
||||
| 225 | 26918593 |
US |
2 | |
Hypersensitivity, |
||||
| 226 | 26918715 |
|||
Hypersensitivity, Pruritus, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 227 | 26918719 |
CN |
48 | 2 |
Flushing, Rash, Blood pressure increased, Heart rate increased, Hypersensitivity, |
||||
CYTARABINE, METHOTREXATE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 228 | 26918825 |
US |
||
Hypersensitivity, |
||||
MITOMYCIN, |
||||
| 229 | 26918970 |
US |
2 | |
Hypersensitivity, |
||||
SUMATRIPTAN SUCCINATE, |
||||
| 230 | 26918980 |
US |
||
Hypersensitivity, |
||||
NIPOCALIMAB-AAHU, |
||||
| 231 | 26919134 |
US |
76 | 2 |
Hypersensitivity, Dry eye, Eye irritation, |
||||
ACOLTREMON, AMLODIPINE, OLMESARTAN MEDOXOMIL, BIOTIN, ROSUVASTATIN, METHENAMINE HIPPURATE, MONTELUKAST, POTASSIUM CITRATE, LEVOTHYROXINE SODIUM, LEVALBUTEROL TARTRATE, |
||||
| 232 | 26919350 |
US |
49 | 2 |
Hypersensitivity, Pruritus, |
||||
ACOLTREMON, GLIPIZIDE, ORAL SEMAGLUTIDE, ICOSAPENT ETHYL, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, |
||||
| 233 | 26919486 |
US |
67 | 2 |
Hypersensitivity, Dry eye, Eye irritation, Eye pain, Vision blurred, Drug ineffective, Pain, Back pain, Arthralgia, Peripheral swelling, Oedema, Off label use, |
||||
ACOLTREMON, |
||||
| 234 | 26919570 |
US |
74 | 2 |
Swelling, Hypersensitivity, Dry eye, |
||||
ACOLTREMON, |
||||
| 235 | 26919677 |
US |
74 | 2 |
Swelling, Hypersensitivity, Ocular discomfort, |
||||
ACOLTREMON, |
||||
| 236 | 26919761 |
US |
62 | 2 |
Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 237 | 26919764 |
US |
73 | 2 |
Hypersensitivity, |
||||
ACOLTREMON, AMLODIPINE BESYLATE, |
||||
| 238 | 26919772 |
US |
62 | 2 |
Ocular hyperaemia, Eye discharge, Eye pruritus, Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 239 | 26919866 |
US |
62 | |
Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 240 | 26920204 |
US |
2 | |
Dizziness, Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 241 | 26920269 |
US |
80 | 2 |
Hypersensitivity, Pruritus, Erythema, |
||||
ACOLTREMON, BIOTIN, CALCIUM, ROSUVASTATIN, LENALIDOMIDE, ESCITALOPRAM, PREGABALIN, MAGNESIUM, PANTOPRAZOLE SODIUM, LEVOTHYROXINE SODIUM, RIVAROXABAN, ACYCLOVIR, |
||||
| 242 | 26920284 |
US |
62 | 2 |
Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 243 | 26920323 |
US |
70 | 2 |
Hypersensitivity, Blepharitis, Rash pruritic, Sinus congestion, Dry eye, |
||||
ACOLTREMON, |
||||
| 244 | 26920329 |
US |
65 | 2 |
Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 245 | 26920371 |
US |
2 | |
Erythema, Rash pruritic, Hypersensitivity, Product administration interrupted, |
||||
ACOLTREMON, CARVEDILOL, FOLIC ACID, LETROZOLE, LETROZOLE TABLETS, LOSARTAN, PANTOPRAZOLE, ZOLEDRONIC ACID, CYCLOSPORINE, SELPERCATINIB, EZETIMIBE, ASPIRIN, ASPIRIN 81 MG DELAYED RELEASE TABLETS, |
||||
| 246 | 26920384 |
US |
86 | 2 |
Hypersensitivity, |
||||
NETARSUDIL, ACOLTREMON, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FAMOTIDINE, BENRALIZUMAB, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ESOMEPRAZOLE MAGNESIUM, RIMEGEPANT SULFATE, FAMOTIDINE, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, DENOSUMAB, CARBOXYMETHYLCELLULOSE SODIUM, METHOCARBAMOL, LATANOPROSTENE BUNOD, |
||||
| 247 | 26920395 |
US |
64 | 2 |
Hypersensitivity, |
||||
ACOLTREMON, FEXOFENADINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GALCANEZUMAB-GNLM, EZETIMIBE, FISH OIL, HYDROXYCHLOROQUINE, LISINOPRIL, RIMEGEPANT SULFATE, PIOGLITAZONE, LANSOPRAZOLE, ERGOCALCIFEROL, |
||||
| 248 | 26920496 |
US |
76 | 1 |
Hypersensitivity, Ocular discomfort, Sneezing, |
||||
ACOLTREMON, AMLODIPINE, CYCLOSPORINE, |
||||
| 249 | 26920638 |
US |
21 | 2 |
Hypersensitivity, |
||||
ACOLTREMON, |
||||
| 250 | 26920803 |
US |
62 | 2 |
Hypersensitivity, Drug ineffective, |
||||
ACOLTREMON, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROXYCHLOROQUINE SULFATE, CYCLOSPORINE, |
||||
| 251 | 26920885 |
US |
33 | |
Hypersensitivity, Rash pruritic, Eyelid margin crusting, Eye pruritus, |
||||
ACOLTREMON, CITALOPRAM, CITALOPRAM HYDROBROMIDE, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, NORETHINDRONE AND ETHINYL ESTRADIOL, PROPRANOLOL HYDROCHLORIDE, |
||||
| 252 | 26921053 |
EU |
64 | 2 |
Acute kidney injury, Hepatic cancer metastatic, Hypersensitivity, Chest discomfort, Ileus, Metastases to peritoneum, General physical health deterioration, |
||||
| 253 | 26921177 |
US |
72 | 1 |
Hypersensitivity, |
||||
ABATACEPT, |
||||
| 254 | 26921194 |
US |
74 | 2 |
Dysphonia, Injection site pain, Hypersensitivity, Injection site mass, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 255 | 26923480 |
63 | 2 | |
Hypersensitivity, |
||||
ORFORGLIPRON, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 256 | 26924021 |
26 | 2 | |
Hypersensitivity, Rash pruritic, Vomiting projectile, Diarrhoea, Abdominal pain, Crying, Rash erythematous, Swelling, Feeling hot, Therapeutic product effect decreased, Dyspnoea, Wheezing, Peripheral swelling, Rash, Brain fog, Panic attack, Product quality issue, |
||||
TIRZEPATIDE, |
||||
| 257 | 26925406 |
42 | 2 | |
Hypersensitivity, |
||||
IXEKIZUMAB, |
||||
| 258 | 26909553 |
US |
1 | |
Eye pruritus, Ocular hyperaemia, Hypersensitivity, |
||||
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, |
||||
| 259 | 26909565 |
US |
32 | 2 |
Constipation, Gastrointestinal pain, Vulvovaginal burning sensation, Erythema, Impaired work ability, Influenza like illness, Insomnia, Hypersensitivity, Dizziness, Fatigue, Myalgia, Body temperature increased, Hyperhidrosis, Urticaria, Rash, Pruritus, Nausea, Abdominal pain, Wrong technique in product usage process, |
||||
TIOPRONIN, POTASSIUM CITRATE, |
||||
| 260 | 26909574 |
TR |
56 | |
Hypersensitivity, Immune tolerance induction, |
||||
RITUXIMAB, RITUXIMAB, METHYLPREDNISOLONE, |
||||
| 261 | 26909692 |
US |
38 | 2 |
Contusion, Urticaria, Hypersensitivity, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, LACTULOSE, EPINEPHRINE, LEVONORGESTREL AND ETHINYL ESTRADIOL, FAMOTIDINE, GABAPENTIN, MELOXICAM, MIRABEGRON, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXCARBAZEPINE, PRAZOSIN, PROPRANOLOL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 262 | 26909725 |
TR |
||
Immune tolerance induction, Hypersensitivity, |
||||
RITUXIMAB, METHYLPREDNISOLONE, |
||||
| 263 | 26909762 |
US |
82 | 1 |
Hypersensitivity, Hypersensitivity, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 264 | 26909763 |
US |
1 | |
Hypersensitivity, |
||||
| 265 | 26909796 |
US |
22 | 2 |
Hypersensitivity, |
||||
| 266 | 26909797 |
TR |
||
Immune tolerance induction, Hypersensitivity, |
||||
RITUXIMAB, METHYLPREDNISOLONE, |
||||
| 267 | 26909868 |
CA |
40 | 2 |
Drug-induced liver injury, Wound infection, Infusion related reaction, Osteoarthritis, Gait inability, Type 2 diabetes mellitus, Adverse reaction, Abdominal pain upper, Nausea, Asthenia, Dizziness, Neck pain, Underdose, Coeliac disease, Joint swelling, Obesity, Hypersensitivity, Hypertension, Folliculitis, Facet joint syndrome, Lung disorder, Psoriatic arthropathy, Grip strength decreased, Muscular weakness, Swelling, Rheumatoid arthritis, Malaise, Confusional state, Drug hypersensitivity, Insomnia, Liver function test increased, Treatment failure, Arthropathy, Night sweats, Blister, Breast cancer stage III, Gastrooesophageal reflux disease, Drug intolerance, Depression, Rash, Blood cholesterol increased, Hepatitis, Gastrointestinal disorder, Contusion, Weight increased, Injection site reaction, Hand deformity, Dyspepsia, Glossodynia, Joint range of motion decreased, Muscle spasms, Musculoskeletal stiffness, Fatigue, Vomiting, Wound, Helicobacter infection, Drug ineffective, Exposure during pregnancy, Maternal exposure during pregnancy, Intentional product use issue, Off label use, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CANDESARTAN, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ERENUMAB-AOOE, |
||||
| 268 | 26910011 |
US |
2 | |
Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 269 | 26910089 |
US |
1 | |
Wheezing, Eosinophilic oesophagitis, Productive cough, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 270 | 26910294 |
US |
70 | 2 |
Oropharyngeal pain, Hypersensitivity, Rash, |
||||
DUPILUMAB, |
||||
| 271 | 26910307 |
US |
56 | 2 |
Pain, Back pain, Hypersensitivity, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, AMMONIUM LACTATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN, AZELASTINE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BENZONATATE, |
||||
| 272 | 26910430 |
US |
||
Gastrointestinal disorder, Hypersensitivity, |
||||
BUPRENORPHINE AND NALOXONE, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, |
||||
| 273 | 26910514 |
US |
||
Hypersensitivity, |
||||
DONANEMAB-AZBT, |
||||
| 274 | 26910703 |
US |
2 | |
Hypersensitivity, Pruritus, Skin irritation, |
||||
CLONIDINE, |
||||
| 275 | 26910791 |
GB |
88 | 2 |
Visual impairment, Asthenia, Dizziness, Hypersensitivity, |
||||
FLUCONAZOLE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLURANDRENOLIDE, BISOPROLOL FUMARATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 276 | 26910912 |
CA |
44 | 2 |
Wound infection, Therapeutic product effect decreased, Hepatic enzyme increased, Wound, Underdose, Maternal exposure during pregnancy, White blood cell count increased, Joint swelling, Intentional product use issue, Therapy non-responder, X-ray abnormal, Dizziness, Adverse drug reaction, Duodenal ulcer perforation, Maternal exposure timing unspecified, Peripheral swelling, Contraindicated product administered, Porphyria acute, Product use in unapproved indication, Live birth, Oedema, Wheezing, Mobility decreased, Sinusitis, Product use issue, Rectal haemorrhage, Medication error, Rash, Hypersensitivity, Discomfort, Abdominal discomfort, Arthropathy, Off label use, Arthralgia, Lower respiratory tract infection, Drug ineffective, Musculoskeletal stiffness, Nausea, Treatment failure, Prescribed overdose, Vomiting, Pancreatitis, Pruritus, Synovitis, Rheumatoid factor positive, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, FOLIC ACID, RITUXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, METHOTREXATE SODIUM, |
||||
| 277 | 26910914 |
CO |
70 | 2 |
Pulmonary oedema, Hypersensitivity, |
||||
IBRUTINIB, LORATADINE, LORATADINE ORAL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 278 | 26910969 |
US |
66 | 2 |
Rash, Hypersensitivity, Product substitution issue, |
||||
LENALIDOMIDE, |
||||
| 279 | 26910999 |
US |
||
Hypersensitivity, |
||||
OCRELIZUMAB, |
||||
| 280 | 26911179 |
CH |
84 | 1 |
Hypersensitivity, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, CEFEPIME HYDROCHLORIDE, CEFEPIME, CLARITHROMYCIN, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 281 | 26911355 |
TR |
||
Immune tolerance induction, Hypersensitivity, |
||||
RITUXIMAB, |
||||
| 282 | 26912032 |
JP |
118 | 2 |
Seizure, Pyrexia, Tremor, Hypersensitivity, Staring, Withdrawal syndrome, Tachycardia, Agitation, Vomiting, |
||||
DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, |
||||
| 283 | 26912180 |
60 | 2 | |
Hypersensitivity, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 284 | 26912190 |
US |
2 | |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 285 | 26912596 |
CA |
||
Colitis ulcerative, Hypersensitivity, Illness, Drug specific antibody, Off label use, |
||||
INFLIXIMAB, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, |
||||
| 286 | 26912613 |
EU |
2 | |
Burns second degree, Product use in unapproved indication, Hypersensitivity, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CAPSAICIN, CAPSAICIN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 287 | 26912722 |
US |
||
Hypersensitivity, Blister, |
||||
DUPILUMAB, |
||||
| 288 | 26912785 |
GB |
1 | |
Dysphagia, Throat tightness, Dyspnoea, Hypersensitivity, Suspected off label use, |
||||
MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), DUTASTERIDE, |
||||
| 289 | 26912919 |
CA |
43 | 2 |
Pulmonary fibrosis, Alopecia, Product use issue, Psoriatic arthropathy, Rheumatoid arthritis, Drug tolerance decreased, Pain, Vomiting, Rheumatic fever, Joint swelling, Musculoskeletal stiffness, Infusion related reaction, Nausea, Therapeutic product effect decreased, Gastrointestinal disorder, Synovitis, Maternal exposure during pregnancy, X-ray abnormal, Rheumatoid factor positive, Product use in unapproved indication, Gait disturbance, Mobility decreased, General physical health deterioration, Pemphigus, Anti-cyclic citrullinated peptide antibody positive, Abdominal discomfort, Pneumonia, Dyspepsia, Arthropathy, Liver injury, Type 2 diabetes mellitus, Contraindicated product administered, Migraine, Live birth, Pericarditis, Drug ineffective, Fatigue, Glossodynia, Hypersensitivity, Swollen joint count increased, Systemic lupus erythematosus, Wound, Incorrect route of product administration, Duodenal ulcer perforation, Hypertension, Blood cholesterol increased, Intentional product use issue, Treatment failure, Drug intolerance, Blister, Discomfort, Rash, Off label use, Hepatic enzyme increased, Arthralgia, Headache, Hand deformity, Swelling, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, |
||||
| 290 | 26912955 |
GT |
74 | 2 |
Immunodeficiency, Hypersensitivity, Pruritus, Skin lesion, Feeling hot, Dry skin, Fatigue, Thermal burn, |
||||
ENFORTUMAB VEDOTIN, |
||||
| 291 | 26913181 |
EU |
||
Hepatotoxicity, Rash maculo-papular, Hypothyroidism, Colitis, Pneumonitis, Alanine aminotransferase increased, Blood alkaline phosphatase increased, Hypersensitivity, Anaemia, Anorectal infection, Aspartate aminotransferase increased, Blood bilirubin increased, Cholangitis, Colitis, Diarrhoea, Fatigue, Dyspnoea, Febrile neutropenia, Gastritis, Hepatotoxicity, Hypertension, Kidney infection, Kidney infection, Pneumonia, Neuralgia, Neutrophil count decreased, Platelet count decreased, Psychotic disorder, Sepsis, Embolism, Urinary fistula, Urinary tract infection, Uterine infection, Vaginal haemorrhage, Arthritis, Blood corticotrophin decreased, Blood prolactin abnormal, Vision blurred, Blood creatinine increased, Diabetes mellitus, Dry eye, Oesophageal infection, Pyrexia, Gamma-glutamyltransferase increased, Headache, Hyperglycaemia, Hyperthyroidism, Hypomagnesaemia, Hypophysitis, Pain, Peripheral sensory neuropathy, Pharyngitis, Proteinuria, Pruritus, Renal disorder, Urinary tract disorder, Skin disorder, Blood thyroid stimulating hormone increased, |
||||
ATEZOLIZUMAB, ATEZOLIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 292 | 26913227 |
CN |
||
Blindness transient, Hypersensitivity, Ocular discomfort, Ocular hyperaemia, Lacrimation increased, Sneezing, Pyrexia, Chest pain, Eye swelling, |
||||
| 293 | 26913422 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, |
||||
| 294 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 295 | 26913584 |
CA |
44 | 2 |
Liver injury, Vomiting, Sinusitis, Type 2 diabetes mellitus, Therapy non-responder, Headache, Swelling, Hypersensitivity, Stomatitis, Rheumatic fever, Swollen joint count increased, Wheezing, Hypertension, Ill-defined disorder, Gastrointestinal disorder, Hypoaesthesia, Impaired healing, Insomnia, General physical health deterioration, Weight increased, Inflammation, Urticaria, Sleep disorder due to general medical condition, insomnia type, Irritable bowel syndrome, Rash, Nasopharyngitis, Helicobacter infection, Sleep disorder, Pyrexia, Blister, Pruritus, Treatment failure, Therapeutic product effect decreased, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, PANTOPRAZOLE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, SECUKINUMAB, LEFLUNOMIDE, CALCIUM GLUCONATE, CORTISONE ACETATE, CORTISONE ACETATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, GOLIMUMAB, |
||||
| 296 | 26913853 |
US |
63 | 2 |
Pain, Hypersensitivity, |
||||
SIBEPRENLIMAB, |
||||
| 297 | 26913860 |
US |
55 | 1 |
Hypersensitivity, Pruritus, |
||||
SIBEPRENLIMAB, |
||||
| 298 | 26913988 |
CA |
44 | 2 |
Blister, Gastrointestinal disorder, General physical health deterioration, Headache, Helicobacter infection, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Insomnia, Irritable bowel syndrome, Liver injury, Nasopharyngitis, Pruritus, Pyrexia, Rash, Rheumatic fever, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, LEFLUNOMIDE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, PANTOPRAZOLE, SECUKINUMAB, ASCORBIC ACID, |
||||
| 299 | 26914043 |
US |
76 | 2 |
Pruritus, Swelling face, Peripheral swelling, Erythema, Hypersensitivity, |
||||
SIBEPRENLIMAB, |
||||
| 300 | 26914047 |
US |
2 | |
Urticaria, Hypersensitivity, |
||||
SIBEPRENLIMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30